Core Laboratories (CLB) Capital Expenditures (2022 - 2026)

Core Laboratories' Capital Expenditures history runs 5 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• On a quarterly basis, Capital Expenditures rose 73.27% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $12.7 million, a 1983.39% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 571.2% from the prior year.
• Capital Expenditures retreated to $3.4 million in Q1 2026 per CLB's latest filing, from $10.2 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $10.2 million in Q4 2025 and bottomed at -$4.3 million in Q3 2024.
• The 5-year median for Capital Expenditures is $2.8 million (2022), against an average of $3.1 million.
• Across the five-year window, Capital Expenditures sank 225.02% in 2024 and jumped 12815.19% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $9.5 million in 2022, then grew by 0.39% to $9.5 million in 2023, then sank by 99.17% to $79000.0 in 2024, then soared by 12815.19% to $10.2 million in 2025, then tumbled by 66.21% to $3.4 million in 2026.
• Per Business Quant, the three latest CLB Capital Expenditures figures stand at $3.4 million (Q1 2026), $10.2 million (Q4 2025), and $187000.0 (Q3 2025).